A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response

Dinah V. Parums

doi:10.12659/MSM.949300

22 April 2025 : Review article

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response

Dinah V. Parums^{DEF 1*}

DOI: 10.12659/MSM.949300

Med Sci Monit 2025; 31:e949300

Authors information Article notes Copyright and License information

Introduction Methods Used for ctDNA Analysis Limitations of ctDNA Analysis in Clinical Practice Future Directions: Development of a Routine ctDNA Diagnostic for Cancer Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Genomic regions and methods used for circulating DNA (ctDNA) analysis in cancer patients (tumor-informed or non-informed) [12].

Back to the Article

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response

Your Privacy